Back

Defining clinical worsening in adult patients with congenital heart disease and heart failure

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: medical treatment Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Thibault Bourgeois

Catholic University of Leuven, Leuven (Belgium)

8 More presentations in this session

Presentation thumbnail
Dapagliflozin prevents fibrogenic activation in endocardial endothelial cells under altered flow
Ms J. Gaal (Boston, US) Doctor I. Friehs (Boston, US)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors for the treatment of single ventricle circulatory failure in adults with congenital heart disease
Doctor R. Neijenhuis (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Results of CHASM IN ACHD (peer CoacHing Adaptive Self-Management INterventions for young Adults with Congenital Heart Disease) study
Doctor R. Krasuski (Durham, US)
Abstract Slides Video
Presentation thumbnail
Sacubitril/ valsartan in patients with congenital heart disease: a systematic review and meta-analysis
Doctor D. Ntiloudi (Pireas, GR)
Abstract Slides Video
Presentation thumbnail
Sodium-glucose cotransporter-2 inhibitor use in children with left ventricular systolic dysfunction: a matched case-control analysis
Doctor D. Newland (Seattle, US)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: medical treatment

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure
thumbnail
Congress Presentation
Heart failure burden among adults with congenital heart disease
thumbnail
Congress Presentation
Acute and advanced heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources